Endonovo Therapeutics Inc
Company Snapshot: Endonovo Therapeutics Inc
Endonovo Therapeutics, Inc. is an innovative biotechnology company developing bioelectronic devices and therapies for regenerative medicine. Endonovo's Immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation, cell death and the promotion of regeneration. Endonovo's Cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and Time-Varying Electromagnetic Fields (TVEMF) for tissue engineering and cell therapies. The Company's initial concentration is on the treatment of acute and chronic inflammatory conditions of the liver using its proprietary Immunotronics™ platform.
- Oct 13 2017 Endonovo Receives Positive Results from Pre-Clinical Study of Non-Invasive Electroceutical
- Sep 26 2017 Endonovo Therapeutics Provides Update on Pre-Clinical Studies
- Sep 22 2017 Endonovo Therapeutics, Inc. and Kodiak Capital Group, LLC Announce Settlement and Dismissal of Lawsuit
- Jun 29 2017 Endonovo Therapeutics Issues Open Letter and Update to Its Shareholders